STLN
Starling Oncology, Inc.
NASDAQ · Healthcare · Medical - Care Facilities · US
$6.84
+7.89%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- 75.70x
- P/S forward
- 0.85x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- -27.98x
- Price / sales
- 1.19x
- Price / cash flow
- 2125.45x
Enterprise value
- Enterprise value
- $760.5M
- EV / sales
- 1.30x
- EV / EBITDA
- -34.80x
- EV / EBIT
- -29.15x
- Market cap
- $697.1M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026